PAR PHARMACEUTICAL

Business Nature: Manufacturer

Company Overview:

Par Pharmaceutical (Taiwan) operates as a high-standard pharmaceutical manufacturing facility. It focuses on the development, production, and supply of complex generic drugs and specialty pharmaceutical products. The company utilizes advanced manufacturing technologies and adheres to strict international quality management systems to ensure compliance with global regulatory standards, including those of the U.S. Food and Drug Administration (FDA). As a subsidiary of a global pharmaceutical entity, the Taiwan site plays a critical role in the company's international supply chain, specializing in the production of finished dosage forms for both local and export markets.

Par Pharmaceutical does not have operations in Taiwan, nor does it manufacture or sell products specifically for the Taiwan market. Par Pharmaceutical is a United States-based subsidiary of Endo International plc, primarily focused on the development, manufacture, and distribution of generic and branded specialty pharmaceuticals for the U.S. healthcare market.

As a result, there is no official product list for Par Pharmaceutical in Taiwan. Their product portfolio is strictly regulated and marketed within the United States.